<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="82796">
  <stage>Registered</stage>
  <submitdate>5/05/2008</submitdate>
  <approvaldate>8/05/2008</approvaldate>
  <actrnumber>ACTRN12608000236392</actrnumber>
  <trial_identification>
    <studytitle>Placebo controlled,randomised,crossover study of the efficacy of bosentan in the management of patients with Coronary Slow Flow Phenemenon</studytitle>
    <scientifictitle>Study of bosentan in the management of angina in patients with Coronary Slow Flow phenomenon</scientifictitle>
    <utrn />
    <trialacronym>Nil</trialacronym>
  </trial_identification>
  <conditions>
    <healthcondition>Coronary Slow Flow Phenomenon</healthcondition>
    <conditioncode>
      <conditioncode1>Cardiovascular</conditioncode1>
      <conditioncode2>Coronary heart disease</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Bosentan 125mgs orally twice daily for 4 weeks with 1 week washout prior to crossover</interventions>
    <comparator>matching capsule containing inactive substance orally, twice daily for 4 weeks</comparator>
    <control>Placebo</control>
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Angina frequency</outcome>
      <timepoint>Week 4 and week 9 assessed by angina diary recorded by patient</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Nitrate consumption</outcome>
      <timepoint>Week 4 and week 9  assessed by angina diary recorded by patient</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Quality of life indices measured are Seattle Angina Questionnaire ,SF 36, Quality of Life Scale</outcome>
      <timepoint>Week 4 and week 9</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Coronary Slow Flow Phenomenon. Angina frquency&gt;3 episodes/week</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Pulmonary hypertension,liver disease.Cyclosporin,glibenclamide,ketoconazole</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Concealment via central randomisation by fax</concealment>
    <sequence>Permuted Block Allocation</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Crossover</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 2 / Phase 3</phase>
    <anticipatedstartdate>28/05/2007</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>26</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
    <postcode>5011</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>Cenral Northern Adelaide Health Service - The Queen Elizabeth Hospital</primarysponsorname>
    <primarysponsoraddress>28 Woodville Rd Woodville 5011</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Government body</fundingtype>
      <fundingname>National Heart Foundation grant in aid</fundingname>
      <fundingaddress>411 King St West melbourne 3003</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary />
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Central Northern Adelaide Health Service</ethicname>
      <ethicaddress>28 Woodville Rd
Woodville 5011</ethicaddress>
      <ethicapprovaldate>7/06/2006</ethicapprovaldate>
      <hrec>2006039</hrec>
      <ethicsubmitdate>2/03/2006</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Dr John Beltrame</name>
      <address>28 Woodville Rd
Woodville 5011</address>
      <phone>+61 8 82226000</phone>
      <fax />
      <email>john.beltrame@adelaide.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr John Beltrame</name>
      <address>28 Woodville Rd
Woodville 5011</address>
      <phone>+61 8 82226000</phone>
      <fax />
      <email>john.beltrame@adelaide.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr John Beltrame</name>
      <address>28 Woodville Rd
Woodville 5011</address>
      <phone>+61 8 82226000</phone>
      <fax />
      <email>john.beltrame@adelaide.edu.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>